EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

TPS41 - Allergen immunotherapy 3

Saturday 01 Jun, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants
Clinical Evaluation of subcutaneous immunotherapy (SCIT) containing a mixture of mites, in depot polymerized formulation without dilutional effect. Results from a prospective multicenter study
Demystifying the fear of lack of adherence to sublingual immunotherapy (SLIT)
Descriptive study of the evolution of patients after oral immunotherapy with milk at the Hospital Universitario Fundación Alcorcón
Efficacy and safety of sublingual immunotherapy for mite in children and adolescents with AR
HDM-SLIT in general practices vs outpatient clinics
House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents
Real world data on persistence and compliance with sublingual allergen specific immunotherapy, a Dutch experience
Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes
Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in pediatric patients with allergic rhinitis due to house dust mites or pollens
The Effect of Japanese cedar pollen SLIT-tablets increases with years of treatment
The change in quality of life of adults with food allergy treated with oral immunotherapy
The effect of the sphenopalatine ganglion acupuncture on the clinical efficacy of cluster immunotherapy in patients with allergic rhinitis
Therapeutic efficacy of a biodegradable microneedle patch loaded with peanut allergen in a peanut allergy model
When gym gains collide with an allergic reaction to whey protein

Chairs

Speakers